ChromaDex Corporation (NASDAQ:CDXC) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
ChromaDex Corporation (CDXC)
NASDAQ:AMEX Investor Relations:
investors.chromadex.com
Company Research
Source: Yahoo! Finance
ChromaDex Corporation isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter ( see the details here Operator: Ladies and gentlemen, thank you for standing by. And welcome to ChromaDex Corporation's First Quarter of 2024 Earnings Conference Call. My name is Jericho and I will be the conference operator today. At this time, all participants are in listen-only mode. And as a reminder, this conference call is being recorded. This afternoon, ChromaDex issued a news release announcing the company's financial results for the first quarter of 2024. If you have not reviewed this information, both are available within the Investor Relations section of ChromaDex's Web site at www.ChromaDex.com. I would now like to turn the conference call over to Ben Shamsian, Vice President of Lytham Partners. Please go ahead, Mr. Shamsian. Ben Shamsian: Thank you. Good afternoon. And welcome to ChromaDex Corporation's first quarter of 2024 results investor call. With us
Show less
Read more
Impact Snapshot
Event Time:
CDXC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDXC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDXC alerts
High impacting ChromaDex Corporation news events
Weekly update
A roundup of the hottest topics
CDXC
News
- ChromaDex Co. (NASDAQ: CDXC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.MarketBeat
- ChromaDex Corporation Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- ChromaDex Corporation Reports First Quarter 2024 Financial ResultsBusiness Wire
- An Intrinsic Calculation For ChromaDex Corporation (NASDAQ:CDXC) Suggests It's 43% Undervalued [Yahoo! Finance]Yahoo! Finance
- ChromaDex's NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy Supplement [Yahoo! Finance]Yahoo! Finance
CDXC
Earnings
- 5/8/24 - Beat
CDXC
Analyst Actions
- 5/9/24 - HC Wainwright
CDXC
Sec Filings
- 5/8/24 - Form 8-K
- 5/8/24 - Form 10-Q
- 4/25/24 - Form ARS
- CDXC's page on the SEC website